🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: \- To assess the efficacy of eplivanserin 5mg/day in co...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-12
Trial ID
NCT00805350
Treatments Being Tested
The purpose of the study is to assess efficacy and safety of eplivanserin i...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2005-11
Trial ID
NCT00253968
Treatments Being Tested
The primary objective is to compare the potential for next-day residual eff...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-04
Trial ID
NCT00679900
Treatments Being Tested
Given the potential age-related differences in safety, tolerability, pharma...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-06
Trial ID
NCT00913614
Treatments Being Tested
Fibromyalgics frequently report sleep disturbances, in particular poor and ...
Status
Completed
Location
Radiant Research
Start Date
2004-04
Trial ID
NCT00313885
Treatments Being Tested
The purpose of the study is to assess efficacy and safety of eplivanserin i...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2005-11
Trial ID
NCT00253903
Treatments Being Tested
The aim of the study is to confirm the efficacy of eplivanserin 5mg/day on ...
Status
Completed
Location
Sanofi-Aventis
Start Date
2006-02
Trial ID
NCT00308503
Treatments Being Tested